Routes of
administration Oral CAS Number 934240-30-9 ChemSpider 13174481 | ATC code None PubChem CID 16046068 Molar mass 314.3541 g/mol | |
 | ||
Synonyms CNV1014802, GSK-1014802, BIIB 074 | ||
Raxatrigine (INN, USAN) is an analgesic under development by Convergence Pharmaceuticals for the treatment of lumbosacral radiculopathy (sciatica) and trigeminal neuralgia (TGN). It acts as a selective, small-molecule, state-dependent Nav1.7 voltage-gated sodium channel blocker. In June 2014, Convergence presented positive results for a phase II clinical study of raxatrigine in the treatment of TGN, including findings that the drug had an excellent efficacy and safety profile and was well-tolerated.
References
Raxatrigine Wikipedia(Text) CC BY-SA